Skip to main content
Accessibility  |  Contact  |  Privacy  |  Terms of Service

Curemark Adds Two Autism Trial Sites in California

  • Published: 2010-10-28 : Author: Curemark, LLC
  • Synopsis: Curemark announces it has added two sites in California to its Phase III clinical trial program for CM-AT autism treatment.

Main Document

Curemark, LLC, (, a drug research and development company focused on the treatment of neurological diseases, announced that it has added two sites in California to its Phase III clinical trial program for CM-AT, the company's autism treatment.

The new sites are the University of California San Francisco (UCSF) and the Neuropsychiatric Research Center of Orange County (NRC) in Santa Ana. Curemark opened CM-AT clinical trial enrollment at the UC Davis MIND Institute in Sacramento earlier this year. The company now has 15 trial sites across the U.S. targeting to enroll a total 170 children in the study.

"We now have trial sites participating in the autism study in major centers throughout California," said Dr. Joan Fallon, Curemark founder and CEO. "There has been substantial interest in the CM-AT trials and we're continuing to expand the number of sites around the country."

CM-AT, which has received Fast Track status from the FDA, targets enzyme deficiencies in autistic children, resulting in an inability to digest protein. The inability to digest protein affects the availability of amino acids, the building blocks of chemicals essential for brain function. If approved, CM-AT will be one of the first therapies to address the underlying physiology of autism.

For information on enrolling in the Curemark CM-AT autism trials, log on to and search "Curemark."

About CUREMARK LLC -Curemark is a drug research and development company focused on the treatment of neurological and other diseases, especially those with dysautonomic components, by addressing certain key gastrointestinal/pancreatic secretory deficiencies. The company's initial products are based upon breakthrough observations by its founder, Dr. Joan Fallon, which revealed a lack of protein digestion in children with autism and ADHD. To learn more about our innovative science, visit

Safe Harbor Statement -This news release contains forward-looking statements that involve risks and uncertainties that could cause our actual results and experiences to differ materially from anticipated results and expectations expressed in such forward-looking statement. These forward-looking statements include, without limitation, statements regarding the mechanism of action of CM-AT, its potential advantages, its potential for use in treating autism, as well as the timing, progress and anticipated results of the clinical development and regulatory processes concerning CM-AT. These statements are based on our current beliefs and expectations as to such future outcomes, and are subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the statements made. Factors that might cause such a material difference include, among others, risks that the results of clinical trials will not support our claims or beliefs concerning the effectiveness of CM-AT, our ability to finance our development of CM-AT, regulatory risks, and our reliance on third party researchers and other collaborators. We assume no obligation to update these statements, except as required by law.

Similar Topics

1 : Pediatric Neural Tumor Shrinkage Shown in Selumetinib Clinical Trial : NIH/National Cancer Institute.
2 : Antidote: A Digital Health Company on a Mission : Grace McElroy Head of Partnerships and Distribution, TrialReach.
3 : Evaluating FDA Approach to Cancer Clinical Trials : Richard Pazdur, M.D..
4 : AST-OPC1 Clinical Study for Spinal Cord Injury Patients : Asterias Biotherapeutics.
5 : UK Clinical Trial to Test Treatments for Vitiligo : Nottingham Clinical Trials Unit, University of Nottingham.
From our Clinical Trials section - Full List (71 Items)

Submit disability news, coming events, as well as assistive technology product news and reviews.

Loan Information for low income singles, families, seniors and disabled. Includes home, vehicle and personal loans.

Famous People with Disabilities - Well known people with disabilities and conditions who contributed to society.

List of awareness ribbon colors and their meaning. Also see our calendar of awareness dates.

Blood Pressure Chart - What should your blood pressure be, and information on blood group types/compatibility.

1 : How Often Do Medical Problems Lead to Bankruptcy?
2 : Videocamp Launches $400,000 Fund and Challenges Filmmakers to Create a Film About Inclusive Education
3 : vEAR: Why Can I Sometimes 'Hear' Silent Flashes When Viewing Animated Gif's?
4 : New Jersey Digital Art Program for Individuals with ASD
5 : 2018 Lime Connect Fellowship Program for Students with Disabilities


Disclaimer: This site does not employ and is not overseen by medical professionals. Content on Disabled World is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. See our Terms of Service for more information.

Reporting Errors: Disabled World is an independent website, your assistance in reporting outdated or inaccurate information is appreciated. If you find an error please let us know.